Discover / Filter / Explore

Stock screener

Find the businesses that fit your questions.

Each company's latest annual period, from SEC filings. Monetary filters use the selected currency; amounts are never converted. Companies with no annual report in the last 18 months are left out unless you include them.

463 companies

Ticker	Company	Revenue ▾	Net income	Net margin	Return on equity	Revenue growth	Diluted EPS
BBIO	BridgeBio Pharma, Inc. Manufacturing · Year ended 2025-12-31 · USD	$502.08M	-$732.94M	-146.0%	n/a	126.3%	-$3.78
TVTX	Travere Therapeutics, Inc. Manufacturing · Year ended 2025-12-31 · USD	$490.73M	-$25.55M	-5.2%	-22.2%	110.5%	-$0.29
NATR	Nature's Sunshine Products Inc Manufacturing · Year ended 2025-12-31 · USD	$480.14M	$20.45M	4.3%	12.7%	5.7%	$1.06
ZLAB	Zai Lab Ltd Manufacturing · Year ended 2025-12-31 · USD	$457.18M	-$175.54M	-38.4%	-24.5%	15.0%	-$0.16
INVA	Innoviva, Inc. Manufacturing · Year ended 2025-12-31 · USD	$411.33M	$271.17M	65.9%	23.1%	14.7%	$3.30
ARDX	Ardelyx, Inc. Manufacturing · Year ended 2025-12-31 · USD	$407.32M	-$61.60M	-15.1%	-36.9%	22.1%	-$0.26
SVA	Sinovac Biotech Ltd Manufacturing · Year ended 2025-12-31 · USD	$386.01M	-$198.84M	-51.5%	-3.1%	6.8%	-$0.83
ARQT	Arcutis Biotherapeutics, Inc. Manufacturing · Year ended 2025-12-31 · USD	$372.07M	-$16.14M	-4.3%	-8.5%	123.4%	-$0.13
MNKD	MannKind Corp Manufacturing · Year ended 2025-12-31 · USD	$348.97M	$5.86M	1.7%	n/a	22.2%	$0.02
CRMD	CorMedix Inc. Manufacturing · Year ended 2025-12-31 · USD	$311.71M	$163.06M	52.3%	40.2%	617.0%	$2.04
EOLS	Evolus, Inc. Manufacturing · Year ended 2025-12-31 · USD	$297.18M	-$51.64M	-17.4%	n/a	11.6%	-$0.80
IRWD	Ironwood Pharmaceuticals Inc Manufacturing · Year ended 2025-12-31 · USD	$296.15M	$24.02M	8.1%	n/a	-15.7%	$0.15
XERS	Xeris Biopharma Holdings, Inc. Manufacturing · Year ended 2025-12-31 · USD	$291.85M	$554.0K	0.2%	4.0%	43.7%	$0.00
HROW	Harrow, Inc. Manufacturing · Year ended 2025-12-31 · USD	$272.30M	-$5.14M	-1.9%	-9.8%	36.4%	-$0.14
VREOF	Vireo Growth Inc. Manufacturing · Year ended 2025-12-31 · USD	$268.77M	-$68.11M	-25.3%	-22.2%	170.4%	-$0.09
LGND	Ligand Pharmaceuticals Inc Manufacturing · Year ended 2025-12-31 · USD	$268.09M	$124.45M	46.4%	12.2%	60.4%	$6.13
ARVN	Arvinas, Inc. Manufacturing · Year ended 2025-12-31 · USD	$262.60M	-$80.80M	-30.8%	-18.6%	-0.3%	-$1.14
SDGR	Schrodinger, Inc. Manufacturing · Year ended 2025-12-31 · USD	$255.87M	-$103.27M	-40.4%	-28.4%	23.3%	-$1.41
RCUS	Arcus Biosciences, Inc. Manufacturing · Year ended 2025-12-31 · USD	$247.00M	-$353.00M	-142.9%	-55.9%	-4.3%	-$3.29
KROS	Keros Therapeutics, Inc. Manufacturing · Year ended 2025-12-31 · USD	$244.06M	$87.01M	35.7%	28.7%	n/m	$2.30
AKBA	Akebia Therapeutics, Inc. Manufacturing · Year ended 2025-12-31 · USD	$236.20M	-$5.34M	-2.3%	-16.4%	47.5%	-$0.02
ANAB	Anaptysbio, Inc Manufacturing · Year ended 2025-12-31 · USD	$234.60M	-$13.23M	-5.6%	-35.6%	157.0%	-$0.46
PBYI	Puma Biotechnology, Inc. Manufacturing · Year ended 2025-12-31 · USD	$228.37M	$31.11M	13.6%	23.9%	-0.9%	$0.61
IDYA	IDEAYA Biosciences, Inc. Manufacturing · Year ended 2025-12-31 · USD	$218.71M	-$113.70M	-52.0%	-11.1%	n/m	-$1.28
VNDA	Vanda Pharmaceuticals Inc. Manufacturing · Year ended 2025-12-31 · USD	$216.10M	-$220.47M	-102.0%	-67.4%	8.7%	-$3.74

Rows per page: 2550 100